MondayOct 04, 2021 1:15 pm

Researchers Find Colorectal Cancer Cases Are Higher in Minorities

Marvella Ford and Kristin Wallace are among researchers who have studied colorectal cancer disparities and rates. These researchers are becoming increasingly concerned as more young individuals are diagnosed with this cancer. Wallace recently published a study that looked at genetic markers which could explain the disparities in outcomes and diagnoses between whites and African Americans earlier in the year. The study, which was published in “Frontiers in Oncology,” found that in comparison with whites, African Americans had a lower prevalence of rectal noncancerous tumors and were generally more susceptible to noncancerous tumors. The study also found that these lesions had…

Continue Reading

FridayOct 01, 2021 3:28 pm

How Technological Innovation May Transform Alzheimer’s Diagnosis

Each year, we celebrate World Alzheimer’s Day on September 21, hoping that every passing day brings us one step closer to a cure. Alzheimer’s disease is a progressive ailment that destroys an individual’s memory and other important mental functions. Researchers believe that the disease may be caused by an abnormal buildup of proteins around and in brain cells. In its late stage, the disease causes individuals to lose their ability to carry on conversations and respond to their environments. With new cases of the disease developing every three seconds, it becomes even more important to diagnose and treat this disease…

Continue Reading

FridayOct 01, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Launches The Desire Project to Promote MDMA-Assisted Psychotherapy Treatment for HSDD

Although an often unspoken of medical disorder, Hypoactive Sexual Desire Disorder affects approximately 9.5 million women in the U.S. alone The project gathers some of the world’s leading researchers in female sexual desire and psychedelics This is the first-of-its-kind psychedelic-based treatment program targeting this disorder, with potential global implications Clinical trials of MDMA as a treatment for PTSD have shown some success due to targeting the pathways that process fear MINDCURE is working with a molecule that will be first-to-market - MDMA is predicted to be approved by 2023 – this brings them closer to the money Mind Cure Health…

Continue Reading

ThursdaySep 30, 2021 1:24 pm

Seven Symptoms of Brain Cancer You Shouldn’t Ignore

An individual’s lifetime risk of developing a spinal cord or malignant brain tumor is under 1%. The American Cancer Society reveals that even when primary brain tumors do occur, more than half of them are benign, which means that they are not cancerous. Dr. Alyx B. Porter, a neuro-oncologist who is also the medical director of the Mayo Clinic Outpatient Practice in Arizona, states that the main known risk factors for brain tumors are a family history with genetic predisposition to some cancers or tumors and being exposed to radiation. Below are the most common symptoms of a brain tumor,…

Continue Reading

ThursdaySep 30, 2021 11:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Achieves Most Important Milestone Yet with Submission of IND Application for Phase 2a Clinical Trial

Tryp Therapeutics on September 22 submitted an IND application to the FDA to evaluate its oral formulation of synthetic psilocybin, TRP-8802, in a Phase 2a clinical study The study seeks to evaluate TRP-8802 for the treatment of patients with eating disorders and will enroll 10 patients  According to Tryp Chairman and CEO, the submission is the first of several IND filings the company intends to make in the coming months Tryp is also preparing for Phase 2b clinical trials, which will evaluate its proprietary drug candidate, TRP-8803 During a recent investor presentation, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical…

Continue Reading

WednesdaySep 29, 2021 10:53 am

Treatment Modalities for Soft Tissue Sarcomas in the Extremities Differ by Age Group

A new study has found that young individuals suffering from extremity soft tissue sarcoma are less likely to receive radiation and more likely to undergo chemotherapy when compared with older individuals. The study was reported in “JAMA Network Open.” Extremity soft tissues sarcomas are a rare group of tumors that commonly occur in an individual’s extremities. For their research, the scientists carried out a retrospective study that included more than 8,900 patients and compared the utilization of definitive treatment from 2004 to 2014. The cohorts from the National Cancer Database comprised of about 3,750 patients aged 65 and above, roughly…

Continue Reading

TuesdaySep 28, 2021 12:31 pm

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) 10 Years in the Making: Innovation Leads to Multi (Pan)-Cancer Screening

After ten years, the concept of (multi)pan-cancer screening pioneered by AnPac Bio-Medical Science Co., Ltd. (AnPac Bio) has finally been accepted and the industry is shifting toward early screening technology that detects multiple cancers in blood at one time. In 2010, AnPac Bio proposed the theory of multi-cancer screening. At the time, the industry was divided over this innovative approach. The Company, however, persevered with the multi-cancer detection concept in an effort which included multiple patent applications and the launch of full technology and product development to help drive a generational shift in the face of a scientific community that…

Continue Reading

TuesdaySep 28, 2021 11:19 am

RYAH Group Inc. (CSE: RYAH) Provides Insight into Cannabis Medical Space in Brazil

Medical cannabis reform in Brazil is slowly taking shape Challenges include the cost of medical cannabis products and medical cannabis patients living close to available access With its background in connected devices, big data, and technology, RYAH appears well qualified to provide insight on medical cannabis around the world While the cannabis world’s attention is often focused on what’s happening in North America, activity in Latin America may be making significant progress. For example, a recent blog post (https://ibn.fm/t36SM) from RYAH Group (CSE: RYAH) states that “Brazil, one of the region’s largest markets, is quietly, if incrementally, making advances toward…

Continue Reading

TuesdaySep 28, 2021 9:30 am

Study Discovers Link Between Gut Bacteria, Mental Health Conditions

A new study conducted by researchers at the Institute of Psychiatry, Psychology and Neuroscience has discovered an overlapping environment in the gut microbiota of individuals living with mental health conditions such as anxiety, bipolar disorder and depression. Bipolar disorder is a disorder that has been linked to extreme mood swings, which range from manic and emotional highs to depressive lows. On the other hand, gut bacteria is a community of microorganisms that dwell in the human gastrointestinal tract. This includes other microorganism types, as well as viruses, bacteria and fungi. Prior research has highlighted the important role gut bacteria plays…

Continue Reading

MondaySep 27, 2021 1:26 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Reveals Attendance at This Year’s H.C. Wainwright Global Investment Conference

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently revealed its participation at the annual H.C. Wainwright Global Investment Conference, held between September 13-15, 2021 Through its sugarBEAT flagship product, Nemaura has sought to capitalize on the expanding Type 2 Diabetes market, expected to reach an annual value of $59 billion by 2025 Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs; the company’s flagship product, the sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor designed…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000